Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)

NCT05880524 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke
Inflammatory Response

Interventions

DRUG: Dornase Alfa
DRUG: Isotonic Saline Solution

Sponsor

Ludwig-Maximilians - University of Munich

Collaborators

[object Object]
[object Object]